Bryn D. Monnery

Poly(2‐Oxazoline)s – Are They More Advantageous for Biomedical Applications Than Other Polymers?

Ondřej Sedláček, Bryn D. Monnery, Sergey K. Filippov et al. · Macromolecular Rapid Communications · 2012 · 301 citations

The chemistry of poly(2-oxazoline)s

Bart Verbraeken, Bryn D. Monnery, Kathleen Lava et al. · European Polymer Journal · 2016 · 269 citations

Engineering, Polymer Science, Organic Chemistry +4

Cytotoxicity of polycations: Relationship of molecular weight and the hydrolytic theory of the mechanism of toxicity

Bryn D. Monnery, Michael Wright, Rachel Cavill et al. · International Journal of Pharmaceutics · 2017 · 220 citations · Full text

Hydrolytic Theory, Biochemistry, Medicine +6

Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues

Ondřej Sedláček, Bryn D. Monnery, Jana Mattová et al. · Biomaterials · 2017 · 104 citations

Cancer Therapy, Medicinal Chemistry, Oncology +10

μPET imaging of the pharmacokinetic behavior of medium and high molar mass 89 Zr-labeled poly(2-ethyl-2-oxazoline) in comparison to poly(ethylene glycol)

Leonie Wyffels, Thomas Verbrugghen, Bryn D. Monnery et al. · Journal of Controlled Release · 2016 · 89 citations

Ethylene Glycol, Pharmaceutical Science, Engineering +12